[1]
Rivera-Sánchez, F.E., Moreno-Licea, C., Mellado-Orellana, R., González-Santiesteban, S. and de la Peña-López, R. 2022. Pneumonitis, a common adverse event of cyclin-dependent kinase 4/6 inhibitors: a case report. International Journal of Scientific Reports. 8, 3 (Feb. 2022), 78–80. DOI:https://doi.org/10.18203/issn.2454-2156.IntJSciRep20220401.